Phase I dose‐escalation study of capmatinib (
INC
280) in Japanese patients with advanced solid tumors
2019 ◽
Vol 110
(4)
◽
pp. 1340-1351
◽
Taito Esaki
◽
Fumihiko Hirai
◽
Akitaka Makiyama
◽
Takashi Seto
◽
Hideaki Bando
◽
...
2014 ◽
Vol 105
(3)
◽
pp. 347-353
◽
Yuichi Ando
◽
Megumi Inada‐Inoue
◽
Ayako Mitsuma
◽
Takayuki Yoshino
◽
Atsushi Ohtsu
◽
...
2008 ◽
Vol 6
(12)
◽
pp. 134-135
Y. Onozawa
◽
N. Boku
◽
A. Fukutomi
◽
A. Ohtsu
◽
T. Doi
◽
...
2007 ◽
Vol 5
(4)
◽
pp. 114
T. Doi
◽
A. Ohtsu
◽
K. Nakagawa
◽
I. Okamoto
◽
K. Kurei
◽
...
Toshihiko Doi
◽
Yuichi Ando
◽
Hideaki Bando
◽
Takayuki Yoshino
◽
Megumi Inada
◽
...
2014 ◽
Vol 74
(3)
◽
pp. 629-636
◽
Toshihiko Doi
◽
Yusuke Onozawa
◽
Nozomu Fuse
◽
Takayuki Yoshino
◽
Kentaro Yamazaki
◽
...
2012 ◽
Vol 18
(9)
◽
pp. 2658-2667
◽
Klaus Mross
◽
Annette Frost
◽
Simone Steinbild
◽
Susanne Hedbom
◽
Martin Büchert
◽
...
2009 ◽
Vol 66
(4)
◽
pp. 669-680
◽
Francisco Robert
◽
Alan Sandler
◽
Joan H. Schiller
◽
Glenn Liu
◽
Karen Harper
◽
...
2014 ◽
Vol 74
(5)
◽
pp. 917-925
◽
Carlos R. Becerra
◽
Paul Conkling
◽
Nicholas Vogelzang
◽
Hilary Wu
◽
Shengyan Hong
◽
...
2014 ◽
Vol 20
(18)
◽
pp. 4747-4757
◽
Paul Haluska
◽
Michael Menefee
◽
Elizabeth R. Plimack
◽
Jonathan Rosenberg
◽
Donald Northfelt
◽
...
Todd Bauer
◽
David Hong
◽
Neeta Somaiah
◽
Charles Cai
◽
Saeheum Song
◽
...